Piramal Pharma Ltd: Piramal Pharma Limited Announces Consoli

MUMBAI, India, May 24, 2023 /PRNewswire/ -- Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), today announced its consolidated results for the fourth quarter (Q4) and full year FY23 ended

Related Keywords

New York , United States , Dahej , Gujarat , India , Singapore , United Kingdom , Mumbai , Maharashtra , London , City Of , Grangemouth , Falkirk , Riverview , Digwal , Andhra Pradesh , Ahmedabad , Hong Kong , America , Nandini Piramal , Yapan Bio , Gewinn Nur , Hemmo Pharmaceuticals Pvt Ltd , Twitter , Piramal Pharma Limited , Piramal Enterprises Ltd , Convergence Chemical Pvt Ltd , Linkedin , Carlyle Group , Manufacturing Organization , Prnewswire Piramal Pharma Limited , Abbvie Inc , Piramal Pharma Ltd , Piramal Pharma , Piramal Pharma Solutions , Contract Development , Facebook , Allergan India Private , Pharma Limited , Inhalation Anesthesia , India Consumer Healthcare , Business Highlights , Hospital Generics , Pain Management , Consumer Healthcare , Lacto Calamine , Forwarding Agent , Deferred Tax Assets , Primary Number , Eastern Time , London Time , Singapore Time , Hong Kong Time , Piramal Critical Care , Complex Hospital Generics , Allergan India Private Limited , Rights Entitlement , Rights Equity Shares , United States Securities Act , Rights Entitlements ,